Discontinued — last reported Q4 '20

Other

U.S. federal statutory tax

Insmed U.S. federal statutory tax remained flat by 0.0% to $0.05 in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $0.05 to $0.05. Over 4 years (FY 2021 to FY 2025), U.S. federal statutory tax shows relatively stable performance with a 0.0% CAGR.

Analysis

StatementCash Flow Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ1 2017
Last reportedQ4 2020

How to read this metric

Used to evaluate how much the company's actual tax rate deviates from the standard federal rate due to specific tax policies or credits.

Detailed definition

The reconciliation of the company's effective tax rate to the statutory federal tax rate. It highlights the impact of fe...

Peer comparison

Standard disclosure in the tax footnote for all US corporations.

Metric ID: other_effective_income_tax_rate_reconciliation_at_federa_740d47

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$0.21$0.21$0.21$0.21$0.21
YoY Change—+0.0%+0.0%+0.0%+0.0%
Range$0.21 – $0.21
CAGR+0.0%
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak4+ years growth

Frequently Asked Questions

What is Insmed's u.s. federal statutory tax?
Insmed (INSM) reported u.s. federal statutory tax of $0.05 in Q4 2025.
How has Insmed's u.s. federal statutory tax changed year-over-year?
Insmed's u.s. federal statutory tax decreased by 0.0% year-over-year, from $0.05 to $0.05.
What is the long-term trend for Insmed's u.s. federal statutory tax?
Over 4 years (2021 to 2025), Insmed's u.s. federal statutory tax has grown at a 0.0% compound annual growth rate (CAGR), from $0.21 to $0.21.
What does u.s. federal statutory tax mean?
The base federal tax rate applied to the company's earnings.